Comparison of the Efficiency of Transduction of Leukemic Cells by Fiber-Modified Adenoviruses
- 1 December 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 15 (12) , 1229-1242
- https://doi.org/10.1089/hum.2004.15.1229
Abstract
Efficient gene transfer with adenoviral type 5 (Ad5) vectors depends on the initial attachment of their fiber, which binds the coxsackie–adenovirus receptor (CAR), and their subsequent internalization, mediated by the interaction of viral penton base with target cell αv integrins. We previously demonstrated that human leukemic cells lack these receptors and are therefore resistant to Ad5 transduction, limiting efforts to genetically modify these cells. Human leukemic blasts are, however, susceptible to transduction with an adenovector made CAR independent by substitution of a chimeric Ad5/35 fiber [Yotnda et al. (2001). Gene Ther. 8, 930–937]. Other receptors can also be targeted with recombinant ligand moieties incorporated into adenovirus fiber. We have determined which of these fiber-modified adenovectors is most effective at modifying human primary leukemia cells, and lines. We used a replication-incompetent Ad5-β-gal vector, in which the Ad5 fiber was replaced with fiber from various adenovirus serotypes (Ad35 and Ad11), or modified either with variable length polylysine (K4, K7, K21) or RGD-4C peptide. All the modified fiber vectors transduced primary leukemia cells and cell lines more efficiently than Ad5. Polylysine-substituted Ad5F/K21 and peptide-modified Ad5F/RGD vectors were most effective overall (up to 100% efficiency), whereas Ad5F/RGD was the most effective at transducing B cell acute lymphoblastic leukemia cells (90% efficiency). Ad5F/K21 and Ad5F/RGD should be of value for the genetic modification of human primary leukemia cells.Keywords
This publication has 44 references indexed in Scilit:
- Short‐term culture of myeloid leukemic cells allows efficient transduction by adenoviral vectorsThe Journal of Gene Medicine, 2004
- The αvβ5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenovirusesGene Therapy, 2003
- Syndecan-1 (CD138) Expression in Acute Myeloblastic Leukemia CellsActa Oncologica, 2003
- Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viabilityThe Journal of Gene Medicine, 2002
- Effects of mitogens on synthesis and distribution of heparan and chondroitin sulphates by human leukemic B, T cells and monocytes studied by high-performance liquid chromatography and radiochemical detectionBiomedical Chromatography, 2001
- A Capsid-Modified Adenovirus Vector Devoid of All Viral Genes: Assessment of Transduction and Toxicity in Human Hematopoietic CellsMolecular Therapy, 2001
- Selective Transduction of Murine Myelomonocytic Leukemia Cells (WEHI-3B) with Regular and RGD-Adenoviral VectorsMolecular Therapy, 2001
- High Expression of Membrane Cofactor Protein of Complement (CD46) in Human Leukaemia Cell Lines: Implication of an Alternatively Spliced Form Containing the STA Domain in CD46 Up‐RegulationScandinavian Journal of Immunology, 1995
- Distribution of C3-Step Regulatory Proteins of the Complement System, CD35 (CRl), CD46 (MCP), and CD55 (DAF), in Hematological MalignanciesLeukemia & Lymphoma, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993